RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes

NCT00379769 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4447

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Rosiglitazone
DRUG: Sulfonylurea
DRUG: Metformin

Sponsor

GlaxoSmithKline